$AYTU
AYTU BIOPHARMA, INC Stock $aytu

$aytu Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000114420416100633 Filed on May 11, 2016

Income Statement

Concept	2016 Q2	2016 Q1	2015 Q2
Revenue	$940.0K	$668.5K	$180.0K
YoY Change	422.22%	2705.58%
Cost Of Revenue	$330.0K	$340.8K	$90.00K
YoY Change	266.67%
Gross Profit	$600.0K	$327.7K	$90.00K
YoY Change	566.67%	1275.4%
Gross Profit Margin	63.83%	49.02%	50.0%
Selling, General & Admin	$3.150M	$2.165M	$1.400M
YoY Change	125.0%	102.33%	13900.0%
% of Gross Profit	525.0%	660.62%	1555.56%
Research & Development	$2.870M	$1.144M	$850.0K
YoY Change	237.65%	64.75%
% of Gross Profit	478.33%	348.95%	944.44%
Depreciation & Amortization	$440.0K	$18.00K	$50.00K
YoY Change	780.0%
% of Gross Profit	73.33%	5.49%	55.56%
Operating Expenses	$6.410M	$3.896M	$2.240M
YoY Change	186.16%	112.9%	22300.0%
Operating Profit	-$5.810M	-$3.227M	-$2.150M
YoY Change	170.23%	78.69%
Interest Expense	-$2.000M	$4.075M	$0.00
YoY Change		11202.2%
% of Operating Profit
Other Income/Expense, Net		-$4.047M
YoY Change		11124.58%
Pretax Income	-$15.30M	-$7.274M	-$2.160M
YoY Change	608.33%	294.86%	21500.0%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$15.30M	-$7.274M	-$2.160M
YoY Change	608.33%	294.86%	21500.0%
Net Earnings / Revenue	-1627.66%	-1088.05%	-1200.0%
Basic Earnings Per Share
Diluted Earnings Per Share	-$20.25B	-$18.54B	-$34.08B
COMMON SHARES
Basic Shares Outstanding	44.86M shares		173.6M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q2	2016 Q1	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.100M	$8.700M	$7.400M
YoY Change	22.97%
Cash & Equivalents	$8.054M	$8.666M	$7.353M
Short-Term Investments	$1.000M
Other Short-Term Assets	$300.0K	$1.100M	$500.0K
YoY Change	-40.0%
Inventory	$524.7K	$621.4K	$39.44K
Prepaid Expenses		$943.1K	$370.9K
Receivables	$162.4K	$84.27K	$157.1K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$10.12M	$10.44M	$8.042M
YoY Change	25.84%	532.35%	143.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$231.4K	$196.9K	$29.71K
YoY Change	679.07%	438.07%	-48.11%
Goodwill	$221.0K	$221.0K	$74.00K
YoY Change	198.65%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.55M	$200.0K	$0.00
YoY Change
Total Long-Term Assets	$14.22M	$11.55M	$10.14M
YoY Change	40.22%	35.06%	16.39%
TOTAL ASSETS
Total Short-Term Assets	$10.12M	$10.44M	$8.042M
Total Long-Term Assets	$14.22M	$11.55M	$10.14M
Total Assets	$24.34M	$21.99M	$18.19M
YoY Change	33.86%	115.51%	51.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.323M	$1.200M	$1.200M
YoY Change	93.55%	119.64%	84.76%
Accrued Expenses	$1.197M	$800.0K	$200.0K
YoY Change	498.55%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$10.10M	$3.205M	$1.478M
YoY Change	583.85%	-65.17%	-75.75%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.200M	$1.200M	$1.100M
YoY Change	281.82%	200.0%
Total Long-Term Liabilities	$4.200M	$1.200M	$1.100M
YoY Change	281.82%	200.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.10M	$3.205M	$1.478M
Total Long-Term Liabilities	$4.200M	$1.200M	$1.100M
Total Liabilities	$14.26M	$4.420M	$2.569M
YoY Change	455.01%	-54.2%	-61.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$46.56M	-$31.26M	-$18.38M
YoY Change	153.31%	147.93%	72.47%
Common Stock	$56.65M	$48.83M	$39.00M
YoY Change	45.26%	271.02%	143.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.09M	$17.57M	$15.62M
YoY Change
Total Liabilities & Shareholders Equity	$24.34M	$21.99M	$18.19M
YoY Change	33.86%	115.51%	51.34%

Cashflow Statement

Concept	2016 Q2	2016 Q1	2015 Q2
OPERATING ACTIVITIES
Net Income	-$15.30M	-$7.274M	-$2.160M
YoY Change	608.33%	294.86%	21500.0%
Depreciation, Depletion And Amortization	$440.0K	$18.00K	$50.00K
YoY Change	780.0%
Cash From Operating Activities	-$2.670M	-$2.380M	-$1.780M
YoY Change	50.0%	23700.0%	17700.0%
INVESTING ACTIVITIES
Capital Expenditures	-$1.090M	-$70.00K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$3.470M	$0.00	-$1.000M
YoY Change	247.0%
Cash From Investing Activities	-$4.560M	-$80.00K	-$1.000M
YoY Change	356.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.610M	170.0K	8.650M
YoY Change	-23.58%		28733.33%
NET CHANGE
Cash From Operating Activities	-2.670M	-2.380M	-1.780M
Cash From Investing Activities	-4.560M	-80.00K	-1.000M
Cash From Financing Activities	6.610M	170.0K	8.650M
Net Change In Cash	-620.0K	-2.290M	5.870M
YoY Change	-110.56%	22800.0%	29250.0%
FREE CASH FLOW
Cash From Operating Activities	-$2.670M	-$2.380M	-$1.780M
Capital Expenditures	-$1.090M	-$70.00K	$0.00
Free Cash Flow	-$1.580M	-$2.310M	-$1.780M
YoY Change	-11.24%		17700.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29706	USD
CY2016Q1	aytu	Core And Developed Technology Net CoreAndDevelopedTechnologyNet	1201153	USD
CY2016Q1	aytu	Prepaid Research And Development Related Party Noncurrent PrepaidResearchAndDevelopmentRelatedPartyNoncurrent	243967	USD
CY2015Q2	aytu	Core And Developed Technology Net CoreAndDevelopedTechnologyNet	780125	USD
CY2016Q1	us-gaap	Indefinite Lived Contractual Rights IndefiniteLivedContractualRights	1405125	USD
CY2015Q2	us-gaap	Indefinite Lived Contractual Rights IndefiniteLivedContractualRights	711000	USD
CY2016Q1	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	202306	USD
CY2016Q1	us-gaap	Assets Assets	21985580	USD
CY2015Q2	us-gaap	Indefinite Lived Trade Names IndefiniteLivedTradeNames	79000	USD
CY2016Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1177049	USD
CY2016Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	84274	USD
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	157058	USD
CY2016Q1	us-gaap	Inventory Net InventoryNet	621352	USD
CY2015Q2	us-gaap	Inventory Net InventoryNet	39442	USD
CY2016Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	943126	USD
CY2016Q1	us-gaap	Goodwill Goodwill	221000	USD
CY2015Q2	us-gaap	Goodwill Goodwill	74000	USD
CY2016Q1	aytu	Indefinite Lived Intangible Asset In Process Research And Development IndefiniteLivedIntangibleAssetInProcessResearchAndDevelopment	7500000	USD
CY2015Q2	aytu	Accrued Compensation Current AccruedCompensationCurrent	196503	USD
CY2015Q2	aytu	Indefinite Lived Intangible Asset In Process Research And Development IndefiniteLivedIntangibleAssetInProcessResearchAndDevelopment	7500000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	575686	USD
CY2015Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	628776	USD
CY2016Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2888	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2016-03-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001385818
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Document Type DocumentType	10-Q
	dei	Trading Symbol TradingSymbol	AYTU
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	44856459	shares
CY2015Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	370888	USD
CY2016Q1	aytu	Prepaid Research And Development Related Party PrepaidResearchAndDevelopmentRelatedParty	121983	USD
CY2015Q2	aytu	Prepaid Research And Development Related Party PrepaidResearchAndDevelopmentRelatedParty	121983	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	10436570	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	8042432	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	196885	USD
CY2015Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4886	USD
CY2015Q2	us-gaap	Assets Assets	18185379	USD
CY2015Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1195368	USD
CY2016Q1	aytu	Accrued Compensation Current AccruedCompensationCurrent	787954	USD
CY2016Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	85714	USD
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Entity Registrant Name EntityRegistrantName	AYTU BIOSCIENCE, INC
CY2015Q2	aytu	Prepaid Research And Development Related Party Noncurrent PrepaidResearchAndDevelopmentRelatedPartyNoncurrent	335454	USD
CY2016Q1	us-gaap	Liabilities Liabilities	4419907	USD
CY2015Q2	us-gaap	Liabilities Liabilities	2568927	USD
CY2016Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3205333	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1477585	USD
CY2016Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	9797	USD
CY2015Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	USD
CY2016Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	698826	USD
	aytu	Products And Services Revenue ProductsAndServicesRevenue	1560854	USD
	aytu	Products And Services Revenue ProductsAndServicesRevenue	15460	USD
	us-gaap	Licenses Revenue LicensesRevenue	64286	USD
	us-gaap	Licenses Revenue LicensesRevenue	64286	USD
	us-gaap	Revenues Revenues	1625140	USD
	us-gaap	Revenues Revenues	79746	USD
	us-gaap	Cost Of Revenue CostOfRevenue	622222	USD
	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3308009	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2418125	USD
CY2016Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	361607	USD
CY2015Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	425893	USD
CY2016Q1	aytu	Interest Payable Noncurrent InterestPayableNoncurrent	66131	USD
CY2015Q2	aytu	Interest Payable Noncurrent InterestPayableNoncurrent	0	USD
CY2016Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	12009	USD
CY2015Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1449	USD
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	38996367	USD
CY2016Q1	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	0	USD
CY2015Q2	us-gaap	Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock	5000000	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31263967	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18381341	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	17565673	USD
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	15616452	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21985580	USD
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18185379	USD
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	85714	USD
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	2245	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	1426	USD
CY2015Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	664000	USD
CY2016Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	66204	USD
CY2015Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2016Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	48827395	USD
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7353061	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8665835	USD
CY2016Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1154616	USD
CY2015Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	0	USD
CY2016Q1	aytu	Products And Services Revenue ProductsAndServicesRevenue	647112	USD
CY2015Q1	aytu	Products And Services Revenue ProductsAndServicesRevenue	2400	USD
CY2016Q1	us-gaap	Licenses Revenue LicensesRevenue	21429	USD
CY2015Q1	us-gaap	Licenses Revenue LicensesRevenue	21429	USD
CY2016Q1	us-gaap	Revenues Revenues	668541	USD
CY2015Q1	us-gaap	Revenues Revenues	23829	USD
CY2016Q1	us-gaap	Cost Of Revenue CostOfRevenue	340796	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1143676	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	694180	USD
	aytu	Research And Development Related Party ResearchAndDevelopmentRelatedParty	143994	USD
	aytu	Research And Development Related Party ResearchAndDevelopmentRelatedParty	155994	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5670718	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2933506	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8404436	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5480970	USD
	us-gaap	Interest Expense InterestExpense	4428136	USD
	us-gaap	Interest Expense InterestExpense	110900	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4478190	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-110900	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12882626	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5591870	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-23910	USD
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.39
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-1842189	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-7274058	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1842189	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7274058	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-36052	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4046685	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	36052	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	4074668	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1806137	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3227373	USD
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1070091	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2244747	USD
CY2015Q1	aytu	Research And Development Related Party ResearchAndDevelopmentRelatedParty	47998	USD
CY2016Q1	aytu	Research And Development Related Party ResearchAndDevelopmentRelatedParty	47998	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12882626	USD
	us-gaap	Operating Expenses OperatingExpenses	5560716	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5567960	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.82
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.70
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	18828934	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7901426	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	15771692	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7901426	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	547109	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	749810	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	433471	USD
	aytu	Payments For Deposits Investing Activities PaymentsForDepositsInvestingActivities	-1998	USD
	aytu	Payments For Deposits Investing Activities PaymentsForDepositsInvestingActivities	1998	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	118697	USD
CY2015Q1	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	17697	USD
	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	284633	USD
	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease	53091	USD
CY2016Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	27983	USD
CY2015Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-50054	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	3895914	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	1829966	USD
	us-gaap	Operating Expenses OperatingExpenses	10029576	USD
	aytu	Amortization Of Prepaid Research And Development Due To Related Parties AmortizationOfPrepaidResearchAndDevelopmentDueToRelatedParties	91488	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-23910	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	581910	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11233	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	572238	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-496322	USD
	aytu	Increase Decrease In Prepaid Research And Development Due To Related Parties IncreaseDecreaseInPrepaidResearchAndDevelopmentDueToRelatedParties	0	USD
	aytu	Increase Decrease In Prepaid Research And Development Due To Related Parties IncreaseDecreaseInPrepaidResearchAndDevelopmentDueToRelatedParties	-150000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-18319	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-103158	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	0	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-392509	USD
	aytu	Increase Decrease In Accrued Compensation IncreaseDecreaseInAccruedCompensation	591451	USD
	aytu	Increase Decrease In Accrued Compensation IncreaseDecreaseInAccruedCompensation	98949	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	208941	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-42673	USD
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	-10560	USD
	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-64286	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-64286	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	540000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	5000000	USD
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	178338	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	aytu	Warrant Derivative Liability Related To Issuance Of Convertible Promissory Notes WarrantDerivativeLiabilityRelatedToIssuanceOfConvertiblePromissoryNotes	102931	USD
	aytu	Warrant Derivative Liability Related To Issuance Of Convertible Promissory Notes WarrantDerivativeLiabilityRelatedToIssuanceOfConvertiblePromissoryNotes	0	USD
	aytu	Primsol Business Purchase Included In Primsol Payable PrimsolBusinessPurchaseIncludedInPrimsolPayable	1077000	USD
	aytu	Primsol Business Purchase Included In Primsol Payable PrimsolBusinessPurchaseIncludedInPrimsolPayable	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	298322	USD
CY2015Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	12.174	pure
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	73746	USD
	aytu	Amortization Of Prepaid Research And Development Due To Related Parties AmortizationOfPrepaidResearchAndDevelopmentDueToRelatedParties	91487	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7992571	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4846450	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	203577	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-741579	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1998	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	10046924	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3700000	USD
CY2015Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	10142947	USD
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1312774	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1148448	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2639650	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1491202	USD
CY2016Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	97000	USD
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	60000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	1561000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	15000	USD
	us-gaap	License And Maintenance Revenue LicenseAndMaintenanceRevenue	21000	USD
	us-gaap	License And Maintenance Revenue LicenseAndMaintenanceRevenue	64000	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	647000	USD
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	2000	USD
CY2016Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	35000	USD
CY2015Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	3000	USD
CY2016Q1	aytu	Unrecognized Share Based Compensation Expenses UnrecognizedShareBasedCompensationExpenses	1554000	USD
CY2016Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y10M24D
CY2016Q1	aytu	Share Based Compensation Share Warrants Outstanding ShareBasedCompensationShareWarrantsOutstanding	369665	shares
CY2016Q1	aytu	Share Based Compensation Share Warrants Outstanding Weighted Average Exercise Price ShareBasedCompensationShareWarrantsOutstandingWeightedAverageExercisePrice	1.73
CY2015Q2	aytu	Share Based Compensation Share Warrants Outstanding ShareBasedCompensationShareWarrantsOutstanding	102613	shares
CY2015Q2	aytu	Share Based Compensation Share Warrants Outstanding Weighted Average Exercise Price ShareBasedCompensationShareWarrantsOutstandingWeightedAverageExercisePrice	4.53
CY2015	aytu	Class Of Warrant Or Rights Weighted Average Remaining Contractual Term ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm	P2Y11M1D
	aytu	Class Of Warrant Or Rights Weighted Average Remaining Contractual Term ClassOfWarrantOrRightsWeightedAverageRemainingContractualTerm	P3Y9M11D
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	86000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	43000	USD
CY2015Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5200000	USD
CY2015Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	401000	USD
CY2015Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	103000	USD
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1718828000000	shares
CY2016Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	11549010	USD
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22446481	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14259681	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22446481	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14259681	shares
	aytu	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	3942613	USD
	aytu	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-72784	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1036	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5175000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	200000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	29754	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	aytu	Primsol Business Purchase Included In Primsol Payable Gross PrimsolBusinessPurchaseIncludedInPrimsolPayableGross	1250000	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	4268000	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	3700000	USD
	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	The number of shares of Company stock that these warrants will convert into is equal to 8% of the gross number of shares of the Company stock issuable upon conversion of the Notes issued to investors introduced to the Company by the private placement agents pursuant to the private placement memorandum. The exercise price will be the conversion price per share at which the first outstanding Note converts into Company common stock. The warrants have a term of five years from August 31, 2015 due to the conversion setting the price of these warrants (see Note 8).
	us-gaap	Accretion Expense AccretionExpense	3942613	USD
	aytu	Debt Instrument Conversion Premium Percentage DebtInstrumentConversionPremiumPercentage	0.1	pure
CY2016Q1	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	2105000	USD
CY2016Q1	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	674000	USD
	us-gaap	Debt Issuance Costs DebtIssuanceCosts	20000	USD
	aytu	Class Of Warrant Term ClassOfWarrantTerm	P5Y
CY2016Q1	aytu	Warrants Issued To Purchase Of Common Stock WarrantsIssuedToPurchaseOfCommonStock	267052	shares
CY2016Q1	aytu	Warrants Exercise Price Per Share WarrantsExercisePricePerShare	0.65
CY2016Q1	aytu	Warrants Exercisable Term WarrantsExercisableTerm	P5Y
CY2016Q1	us-gaap	Contractual Obligation ContractualObligation	3800000	USD
CY2016Q1	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	427000	USD
CY2016Q1	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	312000	USD
CY2016Q1	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	282000	USD
CY2016Q1	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	0	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	547109	USD
	aytu	Stock Subscription StockSubscription	5000000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	8997957	USD
	aytu	Adjustment For Rounding Of Value Due To Conversion AdjustmentForRoundingOfValueDueToConversion	0	USD
	aytu	Share Based Compensation Share Warrants Issued On Convertible Promisory Notes ShareBasedCompensationShareWarrantsIssuedOnConvertiblePromisoryNotes	267052	shares
	aytu	Share Based Compensation Share Warrants Issued On Convertible Promisory Notes Weighted Average Exercise Price ShareBasedCompensationShareWarrantsIssuedOnConvertiblePromisoryNotesWeightedAverageExercisePrice	0.65
	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P5Y
	aytu	Placement Agents Cash Fee Percentage PlacementAgentsCashFeePercentage	0.08	pure
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On June 8, 2015, in connection with the reincorporation as a Delaware corporation, the Company effected a reverse stock split in which each common stock holder received one share of common stock for every 12.174 shares then outstanding (the “Reverse Stock Split”).
CY2015Q3	aytu	Management Fee Payable Per Month ManagementFeePayablePerMonth	18000	USD
	aytu	Adjustment To Additional Capital Issuance Of Warrants Related To Convertible Promissory Note AdjustmentToAdditionalCapitalIssuanceOfWarrantsRelatedToConvertiblePromissoryNote	87000	USD
	aytu	Adjustment To Additional Capital Issuance Of Warrants Related To Convertible Promissory Note AdjustmentToAdditionalCapitalIssuanceOfWarrantsRelatedToConvertiblePromissoryNote	0	USD
	aytu	Debt Instrument Convertible Beneficial Conversion Feature Net Of Accretion DebtInstrumentConvertibleBeneficialConversionFeatureNetOfAccretion	1001000	USD
	aytu	Debt Instrument Convertible Beneficial Conversion Feature Net Of Accretion DebtInstrumentConvertibleBeneficialConversionFeatureNetOfAccretion	0	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	183000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
	aytu	Primsol Business Purchase Included In Primsol Payable Gross PrimsolBusinessPurchaseIncludedInPrimsolPayableGross	1250000	USD
	us-gaap	Accretion Of Discount AccretionOfDiscount	173000	USD
	us-gaap	Accretion Of Discount AccretionOfDiscount	173000	USD
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	143000	shares
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	143000	shares
CY2016Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1155000	USD
CY2016Q1	aytu	Common Stock Shares Authorized Amendment CommonStockSharesAuthorizedAmendment	100000000	shares
CY2016Q1	aytu	Preferred Stock Shares Authorized Amendment PreferredStockSharesAuthorizedAmendment	10000000	shares
CY2016Q2	us-gaap	Payments For Fees PaymentsForFees	2000000	USD
CY2016Q1	us-gaap	License And Maintenance Revenue LicenseAndMaintenanceRevenue	21000	USD
CY2015Q1	us-gaap	License And Maintenance Revenue LicenseAndMaintenanceRevenue	64000	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Ownshare Lending Arrangement Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts	29754	USD
	us-gaap	Accretion Expense AccretionExpense	3942613	USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	4943073	USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	4943073	USD

Files In Submission

Name	View Source	Status
0001144204-16-100633-index-headers.html	Edgar Link	pending
0001144204-16-100633-index.html	Edgar Link	pending
0001144204-16-100633.txt	Edgar Link	pending
0001144204-16-100633-xbrl.zip	Edgar Link	pending
aytu-20160331.xml	Edgar Link	completed
aytu-20160331.xsd	Edgar Link	pending
aytu-20160331_cal.xml	Edgar Link	unprocessable
aytu-20160331_def.xml	Edgar Link	unprocessable
aytu-20160331_lab.xml	Edgar Link	unprocessable
aytu-20160331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v437748_10q.htm	Edgar Link	pending
v437748_ex31-1.htm	Edgar Link	pending
v437748_ex31-2.htm	Edgar Link	pending
v437748_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AYTU
AYTU BIOPHARMA, INC Stock $aytu

2016 Q2 Form 10-Q Financial Statement

#000114420416100633 Filed on May 11, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU AYTU BIOPHARMA, INC Stock $aytu

2016 Q2 Form 10-Q Financial Statement

#000114420416100633 Filed on May 11, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AYTU
AYTU BIOPHARMA, INC Stock $aytu